Literature DB >> 8862504

A 4-base pair deletion mutation of Gs alpha gene in a Japanese patient with pseudohypoparathyroidism.

M Yokoyama1, K Takeda, K Iyota, T Okabayashi, K Hashimoto.   

Abstract

Mutations in the guanine nucleotide binding protein alpha subunit (Gs alpha) have been found in patients with pseudohypoparathyroidism (PHP). We have screened the Gs alpha gene for mutations in a Japanese patient with this disorder and identified a novel 4-base pair deletion in exon 7 in codons 189-190. This deletion causes a frameshift and if synthesis of a truncated form of Gs alpha occurred, it would likely be biologically inactive. The patient was heterozygous for this deletion. The patient's mother and an unaffected brother were tested for the presence of this mutation. His mother had the same mutation, and although her serum calcium and parathyroid hormone levels were within the normal range, she had subcutaneous calcifications. Thus, this mutation appears to be necessary but not sufficient to cause the complete pseudohypoparathyroidism phenotype and thus, other unknown factors, either genetic or acquired, may be necessary for the full syndrome to occur.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8862504     DOI: 10.1007/bf03349874

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  27 in total

1.  Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy.

Authors:  J L Patten; D R Johns; D Valle; C Eil; P A Gruppuso; G Steele; P M Smallwood; M A Levine
Journal:  N Engl J Med       Date:  1990-05-17       Impact factor: 91.245

2.  Genetic deficiency of the alpha subunit of the guanine nucleotide-binding protein Gs as the molecular basis for Albright hereditary osteodystrophy.

Authors:  M A Levine; T G Ahn; S F Klupt; K D Kaufman; P M Smallwood; H R Bourne; K A Sullivan; C Van Dop
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

Review 3.  Influence of genome imprinting on gene expression, phenotypic variations and development.

Authors:  M A Surani
Journal:  Hum Reprod       Date:  1991-01       Impact factor: 6.918

4.  Pseudohypoparathyroidism: report on a family with four affected sisters.

Authors:  R E Kinard; J E Walton; J A Buckwalter
Journal:  Arch Intern Med       Date:  1979-02

Review 5.  G protein mutations in human disease.

Authors:  L S Weinstein; A Shenker
Journal:  Clin Biochem       Date:  1993-10       Impact factor: 3.281

6.  Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein.

Authors:  M A Levine; R W Downs; A M Moses; N A Breslau; S J Marx; R D Lasker; R E Rizzoli; G D Aurbach; A M Spiegel
Journal:  Am J Med       Date:  1983-04       Impact factor: 4.965

7.  Activity of the stimulatory guanine nucleotide-binding protein is reduced in erythrocytes from patients with pseudohypoparathyroidism and pseudopseudohypoparathyroidism: biochemical, endocrine, and genetic analysis of Albright's hereditary osteodystrophy in six kindreds.

Authors:  M A Levine; T S Jap; R S Mauseth; R W Downs; A M Spiegel
Journal:  J Clin Endocrinol Metab       Date:  1986-03       Impact factor: 5.958

8.  Mutations of the Gs alpha-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis.

Authors:  L S Weinstein; P V Gejman; E Friedman; T Kadowaki; R M Collins; E S Gershon; A M Spiegel
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

9.  Rapid GDP release from Gs alpha in patients with gain and loss of endocrine function.

Authors:  T Iiri; P Herzmark; J M Nakamoto; C van Dop; H R Bourne
Journal:  Nature       Date:  1994-09-08       Impact factor: 49.962

10.  A novel Gs alpha mutant in a patient with Albright hereditary osteodystrophy uncouples cell surface receptors from adenylyl cyclase.

Authors:  W F Schwindinger; A Miric; D Zimmerman; M A Levine
Journal:  J Biol Chem       Date:  1994-10-14       Impact factor: 5.157

View more
  7 in total

1.  Pseudohypoparathyroidism with normocalcemia.

Authors:  N Ozbey
Journal:  J Endocrinol Invest       Date:  2001-09       Impact factor: 4.256

2.  Identification of a novel GNAS mutation for pseudohypoparathyroidism in a Chinese family.

Authors:  Li-Hao Sun; Bin Cui; Hong-Yan Zhao; Bei Tao; Wei-Qing Wang; Xiao-Ying Li; Guang Ning; Jian-Min Liu
Journal:  Endocrine       Date:  2009-04-21       Impact factor: 3.633

3.  TSH receptor and Gs(alpha) genetic analysis in children with Down's syndrome and subclinical hypothyroidism.

Authors:  M Tonacchera; A Perri; G De Marco; P Agretti; L Montanelli; M E Banco; A Corrias; J Bellone; M T Tosi; P Vitti; E Martino; A Pinchera; L Chiovato
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

4.  Frequency and effect on serum TSH of phosphodiesterase 8B (PDE8B) gene polymorphisms in patients with sporadic nonautoimmune subclinical hypothyroidism.

Authors:  P Agretti; G De Marco; C Di Cosmo; B Bagattini; E Ferrarini; L Montanelli; P Vitti; M Tonacchera
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

5.  Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification.

Authors:  N S Adegbite; M Xu; F S Kaplan; E M Shore; R J Pignolo
Journal:  Am J Med Genet A       Date:  2008-07-15       Impact factor: 2.802

Review 6.  Progressive osseous heteroplasia: diagnosis, treatment, and prognosis.

Authors:  Robert J Pignolo; Girish Ramaswamy; John T Fong; Eileen M Shore; Frederick S Kaplan
Journal:  Appl Clin Genet       Date:  2015-01-30

Review 7.  Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement.

Authors:  Giovanna Mantovani; Murat Bastepe; David Monk; Luisa de Sanctis; Susanne Thiele; Alessia Usardi; S Faisal Ahmed; Roberto Bufo; Timothée Choplin; Gianpaolo De Filippo; Guillemette Devernois; Thomas Eggermann; Francesca M Elli; Kathleen Freson; Aurora García Ramirez; Emily L Germain-Lee; Lionel Groussin; Neveen Hamdy; Patrick Hanna; Olaf Hiort; Harald Jüppner; Peter Kamenický; Nina Knight; Marie-Laure Kottler; Elvire Le Norcy; Beatriz Lecumberri; Michael A Levine; Outi Mäkitie; Regina Martin; Gabriel Ángel Martos-Moreno; Masanori Minagawa; Philip Murray; Arrate Pereda; Robert Pignolo; Lars Rejnmark; Rebecca Rodado; Anya Rothenbuhler; Vrinda Saraff; Ashley H Shoemaker; Eileen M Shore; Caroline Silve; Serap Turan; Philip Woods; M Carola Zillikens; Guiomar Perez de Nanclares; Agnès Linglart
Journal:  Nat Rev Endocrinol       Date:  2018-08       Impact factor: 43.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.